Advertisement
Canada markets closed

  • S&P/TSX

    21,947.41
    +124.19 (+0.57%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • DOW

    38,675.68
    +450.02 (+1.18%)
     

  • CAD/USD

    0.7308
    -0.0006 (-0.08%)
     

  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     

  • Bitcoin CAD

    87,075.35
    +2,537.20 (+3.00%)
     

  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     

  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     

  • RUSSELL 2000

    2,035.72
    +19.61 (+0.97%)
     

  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     

  • NASDAQ

    16,156.33
    +315.37 (+1.99%)
     

  • VOLATILITY

    13.49
    -1.19 (-8.11%)
     

  • FTSE

    8,213.49
    +41.34 (+0.51%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • CAD/EUR

    0.6787
    -0.0030 (-0.44%)
     

Abbott & St. Jude NO deal talk; Williams-Sonoma drops outlook; SolarCity upgraded

Susannah Lee

Time for your daily dose of trending tickers, the stocks you're following based on your Yahoo Finance ticker searches.

Williams-Sonoma 

Williams-Sonoma (WSM) did not join the early market rally. Investors turned away after hearing the company issued a weaker outlook for the current quarter and the full year compared to Wall Street's forecast. Williams-Sonoma blamed the effects of the West Coast port disruptions earlier this year. The home furnishings retailer did match second quarter profit of $0.58 a share on better-than-expected revenue growth.

St. Jude Medical & Abbott Laboratories

A potential takeover pushed Saint Jude Medical (STJ) higher. But Abbott Laboratories (ABT) knocked the Financial Times report that it was preparing to make a $25 billion bid for medical device maker, St. Jude. Shares of Abbott Labs also traded in the green. The merger would have given the two companies even more ability to deal with healthcare providers.

ADVERTISEMENT

Get the Latest Market Data and News with the Yahoo Finance App

SolarCity

An upgrade on Wall Street gave SolarCity (SCTY) a reason to rise. The stock was raised at Morgan Stanley to an 'overweight' rating. The firm is maintaining its price target at $93 a share but that's still a 116% increase from Wednesday's closing price. Solar City, which Elon Musk serves as the chairman, is down 21% over the past month.